Literature DB >> 24651102

3D TEE during catheter-based interventions.

Francesco Fulvio Faletra1, Giovanni Pedrazzini2, Elena Pasotti2, Stefano Muzzarelli2, Maria Cristina Dequarti2, Romina Murzilli2, Susanne Anna Schlossbauer2, Iveta Petrova Slater2, Tiziano Moccetti2.   

Abstract

Guidance of catheter-based procedures is performed using fluoroscopy and 2-dimensional transesophageal echocardiography (TEE). Both of these imaging modalities have significant limitations. Because of its 3-dimensional (3D) nature, 3D TEE allows visualizing the entire scenario in which catheter-based procedures take place (including long segments of catheters, tips, and the devices) in a single 3D view. Despite these undeniable advantages, 3D TEE has not yet gained wide acceptance among most interventional cardiologists and echocardiographists. One reason for this reluctance is probably the absence of standardized approaches for obtaining 3D perspectives that provide the most comprehensive information for any single step of any specific procedure. Therefore, the purpose of this review is to describe what we believe to be the most useful 3D perspectives in the following catheter-based percutaneous interventions: transseptal puncture; patent foramen ovale/atrial septal defect closure; left atrial appendage occlusion; mitral valve repair; and closure of paravalvular leaks.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-dimensional transesophageal echocardiography; 3-dimensional transesophageal echocardiography; catheter-based percutaneous interventions

Mesh:

Year:  2014        PMID: 24651102     DOI: 10.1016/j.jcmg.2013.10.012

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  19 in total

1.  Initial clinical experience using the EchoNavigator(®)-system during structural heart disease interventions.

Authors:  Jan Balzer; Tobias Zeus; Katharina Hellhammer; Verena Veulemans; Silke Eschenhagen; Eva Kehmeier; Christian Meyer; Tienush Rassaf; Malte Kelm
Journal:  World J Cardiol       Date:  2015-09-26

Review 2.  Characterization of the rdar morphotype, a multicellular behaviour in Enterobacteriaceae.

Authors:  U Römling
Journal:  Cell Mol Life Sci       Date:  2005-06       Impact factor: 9.261

3.  [Echocardiography : Important diagnostic pillar in cardiology].

Authors:  R Erbel
Journal:  Herz       Date:  2017-05       Impact factor: 1.443

4.  Two-dimensional versus three-dimensional transesophageal echocardiography in percutaneous left atrial appendage occlusion.

Authors:  Witold Streb; Katarzyna Mitręga; Tomasz Podolecki; Magdalena Szymała; Anna Leopold-Jadczyk; Tomasz Kukulski; Zbigniew Kalarus
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

5.  Hybrid Imaging in the Catheter Laboratory: Real-time Fusion of Echocardiography and Fluoroscopy During Percutaneous Structural Heart Disease Interventions.

Authors:  Jan Balzer; Tobias Zeus; Verena Veulemans; Malte Kelm
Journal:  Interv Cardiol       Date:  2016-05

Review 6.  Echocardiographic guidance of interventions in adults with congenital heart defects.

Authors:  Weiyi Tan; Jamil Aboulhosn
Journal:  Cardiovasc Diagn Ther       Date:  2019-10

Review 7.  Intracardiac Echocardiography for Structural Heart and Electrophysiological Interventions.

Authors:  Craig Basman; Yuvrajsinh J Parmar; Itzhak Kronzon
Journal:  Curr Cardiol Rep       Date:  2017-09-06       Impact factor: 2.931

Review 8.  Imaging Modalities in Congenital Heart Disease.

Authors:  Sakshi Sachdeva; Saurabh Kumar Gupta
Journal:  Indian J Pediatr       Date:  2020-04-13       Impact factor: 1.967

9.  The Changing Paradigm in the Treatment of Structural Heart Disease and the Need for the Interventional Imaging Specialist.

Authors:  Nina C Wunderlich; Harald Küx; Felix Kreidel; Ralf Birkemeyer; Robert J Siegel
Journal:  Interv Cardiol       Date:  2016-10

Review 10.  Role of modern 3D echocardiography in valvular heart disease.

Authors:  Takahiro Shiota
Journal:  Korean J Intern Med       Date:  2014-10-31       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.